Home > Financial Ratios > NEULAND LABORATORIES

NEULAND LABORATORIES
EV/Core EBITDA

    Back to All Ratios
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
AD     Remove this Ad

NEULAND LABORATORIES Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 44.7216.898.4210.5617.37

What is the latest EV/Core EBITDA ratio of NEULAND LABORATORIES ?

The latest EV/Core EBITDA ratio of NEULAND LABORATORIES is 44.72 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202544.72
Mar202416.89
Mar20238.42
Mar202210.56
Mar202117.37

How is EV/Core EBITDA of NEULAND LABORATORIES Trending?

Years EV/Core EBITDA % Change
Mar2025 44.72
164.77
Mar2024 16.89
100.59
Mar2023 8.42
-20.27
Mar2022 10.56
-39.21
Mar2021 17.37 -

Other Financial Ratios of NEULAND LABORATORIES


Compare EV/Core EBITDA ratio of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹16,852.4 Cr 9.6% 3.1% 9.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,326.0 Cr -2.2% -1.8% -2.4% Stock Analytics
DIVIS LABORATORIES ₹155,282.0 Cr -1.6% -7.2% 0.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹137,043.0 Cr -4.1% -6.7% 23.9% Stock Analytics
DR REDDYS LABORATORIES ₹99,854.2 Cr -4.7% -7.3% 6.4% Stock Analytics
CIPLA ₹97,115.7 Cr -1.7% -8.4% -16.7% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

9.6%

3.1%

9.5%

SENSEX

1.4%

-7%

-3.9%


You may also like the below Video Courses